The improved reimbursement standards for osteoporosis drugs have created a treatment environment that promotes fracture prevention. Healthcare professionals have pointed out that the treatment continuation rate of osteoporosis patients has been low stressing the importance of continuous treatment to minimize the risk of fracture.

On Sept. 19, Amgen Korea held a media session at the Lotte Hotel in Jung-gu, Seoul, to introduce its treatment strategies in response to the changing osteoporosis treatment environment in Korea.

The Ministry of Health and Welfare expanded the duration of reimbursement for major osteoporosis treatments last month. Previously, only patients with a T-score